Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients with Autoimmune Disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients with Autoimmune Disease
Authors
Keywords
Systemic Lupus Erythematosus, Systemic Lupus Erythematosus Patient, Enterohepatic Recirculation, Lupus Nephritis Patient, Enterohepatic Recycling
Journal
CLINICAL PHARMACOKINETICS
Volume 52, Issue 5, Pages 303-331
Publisher
Springer Nature
Online
2013-03-08
DOI
10.1007/s40262-013-0039-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Change in Pharmacokinetics of Mycophenolic Acid as a Function of Age in Rats and Effect of Coadministered Amoxicillin/Clavulanate
- (2012) Junko Ishizaki et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Diminished Mycophenolic Acid Exposure Caused by Omeprazole May Be Clinically Relevant in the First Week Posttransplantation
- (2012) Elias David-Neto et al. THERAPEUTIC DRUG MONITORING
- Effects of Mycophenolate Mofetil Combined with Corticosteroids for Induction Therapy of Microscopic Polyangiitis
- (2011) Fei Han et al. AMERICAN JOURNAL OF NEPHROLOGY
- Pharmacokinetic Variability of Mycophenolic Acid and Its Glucuronide in Systemic Lupus Erythematosus Patients in Remission Maintenance Phase
- (2011) Yasuaki Mino et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus
- (2011) Catherine M. T. Sherwin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Inosine 5′-monophosphate dehydrogenase activity as a biomarker in the field of transplantation
- (2011) Petra Glander et al. CLINICA CHIMICA ACTA
- Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Area Under the Concentration-Time Curve: Is This Clinically Useful for Dosage Prediction Yet?
- (2011) Christine E. Staatz et al. CLINICAL PHARMACOKINETICS
- Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome
- (2011) X.W. Liu et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Mycophenolic Acid Pharmacokinetics During Maintenance Immunosuppression in African American and Caucasian Renal Transplant Recipients
- (2011) Kathleen M. Tornatore et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A Simultaneous D-Optimal Designed Study for Population Pharmacokinetic Analyses of Mycophenolic Acid and Tacrolimus Early After Renal Transplantation
- (2011) Flora Tshinanu Musuamba et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Omeprazole Impairs the Absorption of Mycophenolate Mofetil But Not of Enteric-Coated Mycophenolate Sodium in Healthy Volunteers
- (2011) M. G. Kees et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission-maintenance phase
- (2011) Y. Mino et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients
- (2011) Sieglinde Kofler et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study
- (2011) D. Ioannides et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study
- (2011) N. Lloberas et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial
- (2011) M. S. Stoenoiu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis
- (2011) X. Li et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
- (2011) Mary Anne Dooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study
- (2011) Sarah Djabarouti et al. ARTHRITIS RESEARCH & THERAPY
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
- (2010) F. A. Houssiau et al. ANNALS OF THE RHEUMATIC DISEASES
- Correlation of IMPDH1 Gene Polymorphisms with Subclinical Acute Rejection and Mycophenolic Acid Exposure Parameters on Day 28 after Renal Transplantation
- (2010) Hideaki Kagaya et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
- (2010) Eid M. El-Shafey et al. Clinical and Experimental Nephrology
- Consensus Report on Therapeutic Drug Monitoring of Mycophenolic Acid in Solid Organ Transplantation
- (2010) D. R.J. Kuypers et al. Clinical Journal of the American Society of Nephrology
- Nonlinear Relationship between Mycophenolate Mofetil Dose and Mycophenolic Acid Exposure: Implications for Therapeutic Drug Monitoring
- (2010) B. C. M. de Winter et al. Clinical Journal of the American Society of Nephrology
- Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis
- (2010) Melanie S. Joy et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Enteric-coated mycophenolate sodium
- (2010) Klemens Budde et al. Expert Opinion On Drug Safety
- Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus
- (2010) Sarah Djabarouti et al. EXPERT OPINION ON PHARMACOTHERAPY
- Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- (2010) Thomas F. Hiemstra et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Population Pharmacokinetics and Pharmacogenetics of Mycophenolic Acid Following Administration of Mycophenolate Mofetil in De Novo Pediatric Renal-Transplant Patients
- (2010) Wei Zhao et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Treating Pemphigus Vulgaris with Prednisone and Mycophenolate Mofetil: A Multicenter, Randomized, Placebo-Controlled Trial
- (2010) Stefan Beissert et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis
- (2010) M Akhyani et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Pharmacokinetics of mycophenolic acid in severe lupus nephritis
- (2010) Paungpaga Lertdumrongluk et al. KIDNEY INTERNATIONAL
- Random pharmacokinetic profiles of EC-MPS in children with autoimmune disease
- (2010) Guido Filler et al. Pediatric Rheumatology
- Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil
- (2010) Olivier Gensburger et al. Pharmacogenetics and Genomics
- Pharmacogenetic influences on mycophenolate therapy
- (2010) Katherine A Barraclough et al. PHARMACOGENOMICS
- Pharmacogenetic Impact of UDP-Glucuronosyltransferase Metabolic Pathway and Multidrug Resistance–Associated Protein 2 Transport Pathway on Mycophenolic Acid in Thoracic Transplant Recipients: An Exploratory Study
- (2010) Lillian S. L Ting et al. PHARMACOTHERAPY
- Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil
- (2010) M. Schaier et al. RHEUMATOLOGY
- Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid and Their Relation to Response to Therapy of Childhood-Onset Systemic Lupus Erythematosus
- (2010) Anna Carmela P. Sagcal-Gironella et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Differences in Clearance of Mycophenolic Acid Among Renal Transplant Recipients, Hematopoietic Stem Cell Transplant Recipients, and Patients With Autoimmune Disease
- (2010) Brenda C M de Winter et al. THERAPEUTIC DRUG MONITORING
- Population Pharmacokinetics of Mycophenolic Acid and Metabolites in Patients With Glomerulonephritis
- (2010) Wai-Johnn Sam et al. THERAPEUTIC DRUG MONITORING
- Evaluation of Limited Sampling Strategies for Mycophenolic Acid After Mycophenolate Mofetil Intake in Adult Kidney Transplant Recipients
- (2010) Katherine A Barraclough et al. THERAPEUTIC DRUG MONITORING
- Customized Mycophenolate Dosing Based on Measuring Inosine-Monophosphate Dehydrogenase Activity Significantly Improves Patientsʼ Outcomes After Renal Transplantation
- (2010) Matthias C. Raggi et al. TRANSPLANTATION
- Proton Pump Inhibitor Co-medication Reduces Active Drug Exposure in Heart Transplant Recipients Receiving Mycophenolate Mofetil
- (2010) A.O. Doesch et al. TRANSPLANTATION PROCEEDINGS
- Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure
- (2010) Susan E. Tett et al. Transplantation Reviews
- A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing—remitting multiple sclerosis (TIME MS)
- (2010) Gina M. Remington et al. Therapeutic Advances in Neurological Disorders
- A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis
- (2010) Elliot M. Frohman et al. Therapeutic Advances in Neurological Disorders
- Proton Pump Inhibitors Reduce Mycophenolate Exposure in Heart Transplant Recipients-A Prospective Case-Controlled Study
- (2009) S. Kofler et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial
- (2009) R. S. Gaston et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Influence of Clinical and Demographic Variables on Mycophenolic Acid Pharmacokinetics in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- (2009) Melanie S Joy et al. ANNALS OF PHARMACOTHERAPY
- Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: Findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial
- (2009) Ellen M. Ginzler et al. ARTHRITIS AND RHEUMATISM
- An Age-Dependent Pharmacokinetic Study of Intravenous and Oral Mycophenolate Mofetil in Combination with Tacrolimus for GVHD Prophylaxis in Pediatric Allogeneic Stem Cell Transplantation Recipients
- (2009) Monica Bhatia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy
- (2009) Laurent R. Chiarelli et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic Study of Mycophenolate Mofetil in Patients with Systemic Lupus Erythematosus and Design of Bayesian Estimator Using Limited Sampling Strategies
- (2009) Noël Zahr et al. CLINICAL PHARMACOKINETICS
- Limited Sampling Models and Bayesian Estimation for Mycophenolic Acid Area under the Curve Prediction in Stable Renal Transplant Patients Co-Medicated with Ciclosporin or Sirolimus
- (2009) Flora T. Musuamba et al. CLINICAL PHARMACOKINETICS
- The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics
- (2009) N Picard et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- UGT1A9 -275T>A/-2152C>T Polymorphisms Correlate With Low MPA Exposure and Acute Rejection in MMF/Tacrolimus-Treated Kidney Transplant Patients
- (2009) R H N van Schaik et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Longitudinal evaluation of mycophenolic acid pharmacokinetics in pediatric kidney transplant recipients. The role of post-transplant clinical and therapeutic variables
- (2009) Luciana Ghio et al. CLINICAL TRANSPLANTATION
- Randomized crossover study to assess the inter- and intrasubject variability of morning mycophenolic acid concentrations from enteric-coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipients
- (2009) Helio Tedesco-Silva et al. CLINICAL TRANSPLANTATION
- A Comparison of Mycophenolate Mofetil with Ciclosporine for the Treatment of Chronic Plaque-Type Psoriasis
- (2009) Stefan Beissert et al. DERMATOLOGY
- Bioavailability of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium Is Differentially Affected by Pantoprazole in Healthy Volunteers
- (2009) Korbinian Rupprecht et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Population Pharmacokinetics of Mycophenolic Acid and Its 2 Glucuronidated Metabolites in Kidney Transplant Recipients
- (2009) Wai-Johnn Sam et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Proton Pump Inhibitor Co-medication Reduces Mycophenolate Acid Drug Exposure in Heart Transplant Recipients
- (2009) Sieglinde Kofler et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
- (2009) G. B. Appel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Long-term study of mycophenolate mofetil treatment in IgA nephropathy
- (2009) Sydney C.W. Tang et al. KIDNEY INTERNATIONAL
- Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study
- (2009) M Roland et al. LUPUS
- Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T>C polymorphism
- (2009) Ferdi Sombogaard et al. Pharmacogenetics and Genomics
- Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
- (2009) David Isenberg et al. RHEUMATOLOGY
- Influence of Lansoprazole and Rabeprazole on Mycophenolic Acid Pharmacokinetics One Year After Renal Transplantation
- (2009) Masatomo Miura et al. THERAPEUTIC DRUG MONITORING
- Limited Sampling Strategies for Therapeutic Drug Monitoring of Mycophenolate Mofetil Therapy in Patients With Autoimmune Disease
- (2009) Brenda C M de Winter et al. THERAPEUTIC DRUG MONITORING
- Inadequate Mycophenolic Acid Exposure and Acute Rejection in Kidney Transplantation
- (2009) A.I. Sánchez-Fructuoso et al. TRANSPLANTATION PROCEEDINGS
- The Prevalence of Uridine Diphosphate-Glucuronosyltransferase 1A9 (UGT1A9) Gene Promoter Region Single-Nucleotide Polymorphisms T-275A and C-2152T and Its Influence on Mycophenolic Acid Pharmacokinetics in Stable Renal Transplant Patients
- (2009) A.I. Sánchez-Fructuoso et al. TRANSPLANTATION PROCEEDINGS
- Corticosteroid Interactions with Cyclosporine, Tacrolimus, Mycophenolate, and Sirolimus: Fact or Fiction?
- (2008) S. Lam et al. ANNALS OF PHARMACOTHERAPY
- Population Pharmacokinetics of Mycophenolic Acid
- (2008) Brenda C M de Winter et al. CLINICAL PHARMACOKINETICS
- Current target ranges of mycophenolic acid exposure and drug-related adverse events: A 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients
- (2008) Dirk R.J. Kuypers et al. CLINICAL THERAPEUTICS
- Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors
- (2008) L’Aurelle A. Johnson et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft
- (2008) Irmgard Neumann et al. EXPERT OPINION ON PHARMACOTHERAPY
- Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil
- (2008) I. Neumann et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis
- (2008) NEUROLOGY
- An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis
- (2008) D. B. Sanders et al. NEUROLOGY
- Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients
- (2008) Sabine Irtan et al. PEDIATRIC NEPHROLOGY
- Pharmacokinetics of Mycophenolic Acid in Patients with Lupus Nephritis
- (2008) Melanie S Joy et al. PHARMACOTHERAPY
- Influence of Drug Transporters and UGT Polymorphisms on Pharmacokinetics of Phenolic glucuronide Metabolite of Mycophenolic Acid in Japanese Renal Transplant Recipients
- (2008) Masatomo Miura et al. THERAPEUTIC DRUG MONITORING
- Comparison of Pharmacokinetics of Mycophenolic Acid and Its Glucuronide Between Patients With Lupus Nephritis and With Kidney Transplantation
- (2008) Yasuaki Mino et al. THERAPEUTIC DRUG MONITORING
- Association of four DNA polymorphisms with acute rejection after kidney transplantation
- (2008) Josep Grinyó et al. TRANSPLANT INTERNATIONAL
- Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial
- (2008) Teun van Gelder et al. TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now